GSK221149A (Retosiban) 50mg
Retosiban (GSK-221,149-A) is an oral drug which acts as a selective, sub-nanomolar (Ki = 0.65 nM) oxytocin receptor antagonist with >1400-fold selectivity[3] over the related vasopressin receptors
Trivial name | GSK221149A (Retosiban) 50mg |
Catalog Number | A13106-50 |
Alternative Name(s) | (3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl]piperazine-2,5-dione |
Molecular Formula | C27H34N4O5 |
CAS# | 820957-38-8 |
SMILES | CC[C@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](C2=COC(=N2)C)C(=O)N3CCOCC3)C4CC5=CC=CC=C5C4 |
Size | 50mg |
Supplier Page | http://www.adooq.com/gsk221149a-retosiban.html |